Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.31 (
AMP-activated protein kinase
)
13,065
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
AMP-activated protein kinase
(
AMPK
) and the histone/protein deacetylase
SIRT1
are fuel-sensing molecules that have coexisted in cells throughout evolution. When a cell's energy state is diminished,
AMPK
activation restores energy balance by stimulating catabolic processes that generate ATP and downregulating anabolic processes that consume ATP but are not acutely needed for survival.
SIRT1
in turn is best known historically for producing genetic changes that mediate the increase in longevity caused by calorie restriction. Although the two molecules have been studied intensively for many years, only recently has it become apparent that they have similar effects on diverse processes such as cellular fuel metabolism, inflammation, and mitochondrial function. In this review we will examine the evidence that these similarities occur because
AMPK
and
SIRT1
both regulate each other and share many common target molecules. In addition, we will discuss the clinical relevance of these interactions and in particular the possibility that their dysregulation predisposes to disorders such as type 2 diabetes and atherosclerotic cardiovascular disease and is a target for their therapy.
...
PMID:AMPK and SIRT1: a long-standing partnership? 2010 37
NAD-dependent deacetylase
SIRT1
is known to be activated by caloric restriction and is related to longevity. A natural polyphenolic compound resveratrol is also shown to increases
SIRT1
activity and extends lifespan. However, the transcriptional regulation of
SIRT1
gene has not completely examined in the context of metabolism. Thus, in this study, we characterized the 5' -flanking region of human
SIRT1
gene. We first found that representative metabolic hormones and related factors (glucocorticoid, glucagon/cAMP, and insulin) did not show significant effect on
SIRT1
gene transcription. PPARalpha and PPARgamma1 without/with their specific ligands did not have significant effect as well. In contrast, expression of PPARbeta/delta (PPARdelta markedly increased the 5' -promoter activity of
SIRT1
gene, which was further amplified by the addition of GW501516, a selective PPARdelta agonist. Deletion/mutation mapping analyses failed to identify PPAR binding element but revealed the presence of canonical Sp1 binding site, which was conserved among species. The Sp1 site is functional, because Sp1 overexpresson significantly enhanced
SIRT1
promoter activity, and the binding of Sp1 to the element was confirmed by EMSA and ChIP assays. Interestingly, specific Sp1 antagonist mithramycin completely abolished the PPARdelta-mediated induction of
SIRT1
gene transcription. Altogether, our data suggest the predominant role of PPARdelta in the transcriptional regulation of
SIRT1
gene. Furthermore, the effects of PPARdelta seem to be mediated by Sp1. We assume that, in vivo, starvation increases lipolysis-derived free fatty acid and activates PPARdelta and the resultant increase in
SIRT1
expression, in addition to the activation by NAD and
AMPK
, facilitates the deacetylation of a variety of proteins involved in mitochondrial beta-oxidation pathway and cell survival.
...
PMID:PPARbeta/delta regulates the human SIRT1 gene transcription via Sp1. 2016 Mar 99
During fasting and after exercise, skeletal muscle efficiently switches from carbohydrate to lipid as the main energy source to preserve glycogen stores and blood glucose levels for glucose-dependent tissues. Skeletal muscle cells sense this limitation in glucose availability and transform this information into transcriptional and metabolic adaptations. Here we demonstrate that
AMPK
acts as the prime initial sensor that translates this information into
SIRT1
-dependent deacetylation of the transcriptional regulators PGC-1alpha and FOXO1, culminating in the transcriptional modulation of mitochondrial and lipid utilization genes. Deficient
AMPK
activity compromises
SIRT1
-dependent responses to exercise and fasting, resulting in impaired PGC-1alpha deacetylation and blunted induction of mitochondrial gene expression. Thus, we conclude that
AMPK
acts as the primordial trigger for fasting- and exercise-induced adaptations in skeletal muscle and that activation of
SIRT1
and its downstream signaling pathways are improperly triggered in
AMPK
-deficient states.
...
PMID:Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. 2019 54
This study was designed to examine potential in vivo mechanisms of
AMP-activated protein kinase
(
AMPK
) phosphorylation inhibition and its downstream signaling consequences during the recovery period after a single bout of sprint exercise. Sprint exercise induces Thr(172)-
AMPK
phosphorylation and increased PGC-1alpha mRNA, by an unknown mechanism. Muscle biopsies were obtained in 15 young healthy men in response to a 30-s sprint exercise (Wingate test) randomly distributed into two groups: the fasting (n = 7, C) and the glucose group (n = 8, G), who ingested 75 g of glucose 1 h before exercising to inhibit AMPKalpha phosphorylation. Exercise elicited different patterns of Ser(221)-ACCbeta, Ser(473)-Akt and Thr(642)-AS160 phosphorylation, during the recovery period after glucose ingestion. Thirty minutes after the control sprint, Ser(485)-AMPKalpha1/Ser(491)-AMPKalpha2 phosphorylation was reduced by 33% coinciding with increased Thr(172)-AMPKalpha phosphorylation (both, P < 0.05). Glucose abolished the 30-min Thr(172)-AMPKalpha phosphorylation. Ser(221)-ACCbeta phosphorylation was elevated immediately following and 30 min after exercise in C and G, implying a dissociation between Thr(172)-AMPKalpha and Ser(221)-ACCbeta phosphorylation. Two hours after the sprint, PGC-1alpha protein expression remained unchanged while
SIRT1
(its upstream deacetylase) was increased. Glucose ingestion abolished the
SIRT1
response without any significant effect on PGC-1alpha protein expression. In conclusion, glucose ingestion prior to a sprint exercise profoundly affects Thr(172)-AMPKalpha phosphorylation and its downstream signaling during the recovery period.
...
PMID:SIRT1, AMP-activated protein kinase phosphorylation and downstream kinases in response to a single bout of sprint exercise: influence of glucose ingestion. 2021 15
Adiponectin is an anti-diabetic adipokine. Its receptors possess a seven-transmembrane topology with the amino terminus located intracellularly, which is the opposite of G-protein-coupled receptors. Here we provide evidence that adiponectin induces extracellular Ca(2+) influx by adiponectin receptor 1 (AdipoR1), which was necessary for subsequent activation of Ca(2+)/calmodulin-dependent protein kinase kinase beta (CaMKKbeta),
AMPK
and
SIRT1
, increased expression and decreased acetylation of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha), and increased mitochondria in myocytes. Moreover, muscle-specific disruption of AdipoR1 suppressed the adiponectin-mediated increase in intracellular Ca(2+) concentration, and decreased the activation of CaMKK,
AMPK
and
SIRT1
by adiponectin. Suppression of AdipoR1 also resulted in decreased PGC-1alpha expression and deacetylation, decreased mitochondrial content and enzymes, decreased oxidative type I myofibres, and decreased oxidative stress-detoxifying enzymes in skeletal muscle, which were associated with insulin resistance and decreased exercise endurance. Decreased levels of adiponectin and AdipoR1 in obesity may have causal roles in mitochondrial dysfunction and insulin resistance seen in diabetes.
...
PMID:Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. 2051 15
In this study, we aim to determine cellular mechanisms linking nutrient metabolism to the regulation of inflammation and insulin resistance. The nutrient sensors
AMP-activated protein kinase
(
AMPK
) and
SIRT1
show striking similarities in nutrient sensing and regulation of metabolic pathways. We find that the expression, activity, and signaling of the major isoform alpha1AMPK in adipose tissue and macrophages are substantially down-regulated by inflammatory stimuli and in nutrient-rich conditions, such as exposure to lipopolysaccharide (LPS), free fatty acids (FFAs), and diet-induced obesity. Activating
AMPK
signaling in macrophages by 5-aminoimidazole-4-carboxamide-1-beta4-ribofuranoside or constitutively active alpha1AMPK (CA-alpha1) significantly inhibits; although inhibiting alpha1AMPK by short hairpin RNA knock-down or dominant-negative alpha1AMPK (DN-alpha1) increases LPS- and FFA-induced tumor necrosis factor alpha expression. Chromatin immunoprecipitation and luciferase reporter assays show that activation of
AMPK
by CA-alpha1 in macrophages significantly inhibits LPS- or FFA-induced NF-kappaB signaling. More importantly, in a macrophage-adipocyte co-culture system, we find that inactivation of macrophage
AMPK
signaling inhibits adipocyte insulin signaling and glucose uptake. Activation of
AMPK
by CA-alpha1 increases the
SIRT1
activator NAD(+) content and
SIRT1
expression in macrophages. Furthermore, alpha1AMPK activation mimics the effect of
SIRT1
on deacetylating NF-kappaB, and the full capacity of
AMPK
to deacetylate NF-kappaB and inhibit its signaling requires
SIRT1
. In conclusion,
AMPK
negatively regulates lipid-induced inflammation, which acts through
SIRT1
, thereby contributing to the protection against obesity, inflammation, and insulin resistance. Our study defines a novel role for
AMPK
in bridging the signaling between nutrient metabolism and inflammation.
...
PMID:Macrophage alpha1 AMP-activated protein kinase (alpha1AMPK) antagonizes fatty acid-induced inflammation through SIRT1. 2042 Dec 94
Shear stress imposed by blood flow is crucial for maintaining vascular homeostasis. We examined the role of shear stress in regulating
SIRT1
, an NAD(+)-dependent deacetylase, and its functional relevance in vitro and in vivo. The application of laminar flow increased
SIRT1
level and activity, mitochondrial biogenesis, and expression of
SIRT1
-regulated genes in cultured endothelial cells (ECs). When the effects of different flow patterns were compared in vitro,
SIRT1
level was significantly higher in ECs exposed to physiologically relevant pulsatile flow than pathophysiologically relevant oscillatory flow. These results are in concert with the finding that
SIRT1
level was higher in the mouse thoracic aorta exposed to atheroprotective flow than in the aortic arch under atheroprone flow. Because laminar shear stress activates
AMP-activated protein kinase
(
AMPK
), with subsequent phosphorylation of endothelial nitric oxide synthase (eNOS) at Ser-633 and Ser-1177, we studied the interplay of
AMPK
and
SIRT1
on eNOS. Laminar flow increased
SIRT1
-eNOS association and eNOS deacetylation. By using the
AMPK
inhibitor and eNOS Ser-633 and -1177 mutants, we demonstrated that
AMPK
phosphorylation of eNOS is needed to prime
SIRT1
-induced deacetylation of eNOS to enhance NO production. To verify this finding in vivo, we compared the acetylation status of eNOS in thoracic aortas from AMPKalpha2(-/-) mice and their AMPKalpha2(+/+) littermates. Our finding that AMPKalpha2(-/-) mice had a higher eNOS acetylation indicates that
AMPK
phosphorylation of eNOS is required for the
SIRT1
deacetylation of eNOS. These results suggest that atheroprotective flow, via
AMPK
and
SIRT1
, increases NO bioavailability in endothelium.
...
PMID:Shear stress, SIRT1, and vascular homeostasis. 2047 54
It is likely that the heritability of T2DM goes beyond simple genetic markers and involves epigenetic mechanisms. Neel's Thrifty Gene Hypothesis was expanded by Chakravarthy to include metabolic cycling and the dissonance between our stone-age genes with a space-age lifestyle. Further modifications of this hypothesis continued after recent developments in evolutionary and epigenetic research. At the molecular forefront, energy-sensing signaling pathways in T2DM, such as PGC1alpha,
AMPK
, O-GlcNAc and most recently
SIRT1
have been shown to play key roles in oxidative stress, mitochondrial dysfunction, inflammation and glucolipotoxicity, which are the hallmarks of insulin resistance and T2DM, Furthermore,
SIRT1
, PGC1alpha and O-GlcNAc also regulate gene expression and may play a role in the epigenetic machinery, thus providing an explanation to how metabolism switches to either a 'thrift' or 'spend' mode depending on food availability. Separate evidence on adaptations to exercise further links T2DM with decreased physical activity. In this review, the major findings from the epigenetic, epidemiological, molecular and clinical forefronts are integrated and unified as a coherent hypothesis for the etiology and pathogenesis of T2DM. It is an opportune time to start connecting the dots to provide the much needed basis for a better understanding of T2DM and a more targeted approach to drug development and treatment strategies.
...
PMID:Connecting the dots: molecular and epigenetic mechanisms in type 2 diabetes. 2052 67
Naringenin, a flavonoid found in high concentrations in grapefruit, has been reported to have antioxidant, antiatherogenic, and anticancer effects. Effects on lipid and glucose metabolism have also been reported. Naringenin is structurally similar to the polyphenol resveratrol, that has been reported to activate the SIRT1 protein deacetylase and to have antidiabetic properties. In the present study we examined the direct effects of naringenin on skeletal muscle glucose uptake and investigated the mechanism involved. Naringenin stimulated glucose uptake in L6 myotubes in a dose- and time-dependent manner. Maximum stimulation was seen with 75 microM naringenin for 2 h (192.8+/-24%, p<0.01), a response comparable to maximum insulin response (190.1+/-13%, p<0.001). Similar to insulin, naringenin did not increase glucose uptake in myoblasts indicating that GLUT4 glucose transporters may be involved in the naringenin-stimulated glucose uptake. In addition, naringenin did not have a significant effect on basal or insulin-stimulated Akt phosphorylation while significantly increased
AMPK
phosphorylation/activation. Furthermore, silencing of
AMPK
, using siRNA approach, abolished the naringenin-stimulated glucose uptake. The
SIRT1
inhibitors nicotinamide and EX527 did not have an effect on naringenin-stimulated
AMPK
phosphorylation and glucose uptake. Our data show that naringenin increases glucose uptake by skeletal muscle cells in an
AMPK
-dependent manner.
...
PMID:Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK. 2055 45
Peroxisome proliferator-activated receptors (PPARs), which are known to regulate lipid homeostasis, are tightly controlled by nutrient availability, and they control nutrient handling. In this paper, we focus on how nutrients control the expression and action of PPARs and how cellular signaling events regulate the action of PPARs in metabolically active tissues (e.g., liver, skeletal muscle, heart, and white adipose tissue). We address the structure and function of the PPARs, and their interaction with other nuclear receptors, including PPAR cross-talk. We further discuss the roles played by different kinase pathways, including the extracellular signal-regulated kinases/mitogen-activated protein kinase (ERK MAPK),
AMP-activated protein kinase
(
AMPK
), Akt/protein kinase B (Akt/PKB), and the NAD+-regulated protein deacetylase
SIRT1
, serving to control the activity of the PPARs themselves as well as that of a key nutrient-related PPAR coactivator, PPARgamma coactivator-1alpha (PGC-1alpha). We also highlight how currently applied nutrigenomic strategies will increase our understanding on how nutrients regulate metabolic homeostasis through PPAR signaling.
...
PMID:PPARs: Nuclear Receptors Controlled by, and Controlling, Nutrient Handling through Nuclear and Cytosolic Signaling. 2081 33
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>